MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nichols, M. R.
Right arrow Articles by Morimoto, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nichols, M. R.
Right arrow Articles by Morimoto, B. H.

Vol. 57, Issue 4, 738-745, April 2000

Differential Inhibition of Multiple cAMP Phosphodiesterase Isozymes by Isoflavones and Tyrphostins

Michael R. Nichols and Bruce H. Morimoto

Department of Chemistry, Purdue University, West Lafayette, Indiana (M.R.N.); and Phoenix International Life Sciences, Inc., Redwood City, California (B.H.M.)

A series of isoflavone and tyrphostin compounds were found to inhibit the degradation of cAMP by several cyclic nucleotide phosphodiesterase (PDE) isozymes. Specific hydroxyl groups on the isoflavone structure were critical for PDE isozyme-selective inhibition. Replacement of the C-7 hydroxyl group of the isoflavone with a methoxy group raised the IC50 for PDE1, PDE3, and PDE4. The absence of the C-5 hydroxyl group raised the IC50 from 5 to >100 µM for PDE4, but actually lowered the IC50 for PDE3 and PDE1. Replacement of the C-4' hydroxyl group with a methoxy group raised the IC50 for PDE3 and PDE1, yet only slightly changed the IC50 for PDE4. Various tyrphostins were also potent inhibitors of PDE1, PDE3, and PDE4. The four-carbon side chained tyrphostins were much less potent; however, a very interesting pattern was observed in which removal of phenolic hydroxyls on the tyrphostin structure increased the potency for PDE1 and PDE3, but not PDE4. These results may help to explain some of the therapeutic and intracellular signaling effects of isoflavones and tyrphostins. Moreover, the isozyme selectivity demonstrated by the isoflavones and tyrphostins can serve as a pharmacophore for the design of specific PDE inhibitors.

Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
M. R. Peluso
Flavonoids Attenuate Cardiovascular Disease, Inhibit Phosphodiesterase, and Modulate Lipid Homeostasis in Adipose Tissue and Liver
Experimental Biology and Medicine, September 1, 2006; 231(8): 1287 - 1299.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Wang, Y. Liu, Q. Huai, J. Cai, R. Zoraghi, S. H. Francis, J. D. Corbin, H. Robinson, Z. Xin, G. Lin, et al.
Multiple Conformations of Phosphodiesterase-5: IMPLICATIONS FOR ENZYME FUNCTION AND DRUG DEVELOPMENT
J. Biol. Chem., July 28, 2006; 281(30): 21469 - 21479.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
S. Missan, P. Linsdell, and T. F. McDonald
Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K+ current in guinea-pig ventricular myocytes
J. Physiol., June 1, 2006; 573(2): 469 - 482.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Liu, L. L. Homan, and J. S. Dillon
Genistein Acutely Stimulates Nitric Oxide Synthesis in Vascular Endothelial Cells by a Cyclic Adenosine 5'-Monophosphate-Dependent Mechanism
Endocrinology, December 1, 2004; 145(12): 5532 - 5539.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. T. Sanderson, J. Hordijk, M. S. Denison, M. F. Springsteel, M. H. Nantz, and M. van den Berg
Induction and Inhibition of Aromatase (CYP19) Activity by Natural and Synthetic Flavonoid Compounds in H295R Human Adrenocortical Carcinoma Cells
Toxicol. Sci., November 1, 2004; 82(1): 70 - 79.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. A. Whitehead, J. E. Cross, C. Burden, and M. Lacey
Acute and chronic effects of genistein, tyrphostin and lavendustin A on steroid synthesis in luteinized human granulosa cells
Hum. Reprod., March 1, 2002; 17(3): 589 - 594.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics